AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ORTHOCELL LTD

0.680

+0.0101.49%

Volume:703.73K

Turnover:487.30K

Market Cap:184.34M

PE:-12.83

High:0.740

Open:0.740

Low:0.670

Close:0.670

52wk High:1.490

52wk Low:0.670

Shares:271.09M

Float Shares:194.08M

Volume Ratio:1.86

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.053

EPS(LYR):-0.053

ROE:-56.82%

ROA:-25.52%

PB:5.36

PE(LYR):-12.83

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-0.09%

Capital Flow

Inflow:

Outflow:

News

Orthocell to Present Initial Five-Patient Case Series for Use of Nerve Repair Product in Patients Undergoing Prostatectomy; Shares Up 4%

MT Newswires Live

Orthocell Ltd-Change of Auditor

THOMSON REUTERS

Orthocell Achieves First Commercial Sales of Nerve Repair Product in Thailand

MT Newswires Live

Australia's Orthocell Rises as Flagship Product Records First Thailand Sales

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigermarketd.com/stock/OCC.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCC.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","market":"AU","secType":"STK","nameCN":"ORTHOCELL LTD","latestPrice":0.68,"timestamp":1791868320000,"preClose":0.67,"halted":0,"volume":703725,"delay":0,"changeRate":0.01492537313432837,"nameEN":"ORTHOCELL LTD","floatShares":194076512,"shares":271090199,"eps":-0.053,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"10-13 16:12:00 AEDT","open":0.74,"high":0.74,"low":0.67,"amount":487304,"amplitude":0.104478,"askPrice":0.68,"askSize":14924,"bidPrice":0.67,"bidSize":17348,"shortable":3,"etf":0,"ttmEps":-0.053,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791932400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.67,"openAndCloseTimeList":[[1791846000000,1791867600000]],"volumeRatio":1.85848,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"OCC.AU","preClose":0.67,"auctionPrice":0.68,"auctionVolume":144,"auction":3,"marketStatus":"盘后竞价","timestamp":1791868199328}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OCC.AU\",,,,,undefined,":{"symbol":"OCC.AU","floatShares":194076512,"roa":"-25.52%","roe":"-56.82%","lyrEps":-0.053,"volumeRatio":1.85848,"shares":271090199,"dividePrice":0,"high":0.74,"amplitude":0.104478,"preClose":0.67,"low":0.67,"week52Low":0.67,"pbRate":"5.36","psRate":"16.16","week52High":1.49,"institutionHeld":0,"latestPrice":0.68,"committee":0.075112,"eps":-0.053,"divideRate":0,"volume":703725,"delay":0,"ttmEps":-0.053,"open":0.74,"prevYearClose":1.085,"prevWeekClose":0.69,"prevMonthClose":0.765,"prevQuarterClose":0.765,"fiveDayClose":0.72,"twentyDayClose":0.71,"sixtyDayClose":0.715},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCC.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-13","symbol":"OCC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1783900800000,"name":null,"time":"","dateTimestamp":1783864800000,"actualEps":null},{"date":"2026-04-20","symbol":"OCC.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"","dateTimestamp":1776607200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCC.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCC.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2675386910","title":"Orthocell to Present Initial Five-Patient Case Series for Use of Nerve Repair Product in Patients Undergoing Prostatectomy; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675386910","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675386910?lang=en_us&edition=fundamental","pubTime":"2026-10-13 08:30","pubTimestamp":1791851437,"startTime":"0","endTime":"0","summary":"Orthocell  will present an initial five-patient case series for the use of its Remplir nerve repair product in prostatectomy procedures in clinically complex patients as a pilot for early functional recovery data, according to a Tuesday Australian bourse filing.Remplir was placed in all five patients undergoing robotic prostatectomy, per the filing. All patients underwent extensive removal of tumor tissue with nerve preservation only feasible on one side, with 80% of the patients demonstrating \"encouraging\" urinary continence outcomes, and 75% of patients with erectile function prior to surgery showed a return of erectile function.The case series will inform a planned prospective clinical trial, which will investigate the product's potential to support an earlier return of erectile function and urinary continence following radical robotic prostatectomys with advanced prostate cancer.The biotech company's shares advanced past 4% in recent trading on Tuesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","OCC.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672793108","title":"Orthocell Ltd-Change of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2672793108","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672793108?lang=en_us&edition=fundamental","pubTime":"2026-10-02 09:04","pubTimestamp":1790903059,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUECB442V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","OCC.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669310139","title":"Orthocell Achieves First Commercial Sales of Nerve Repair Product in Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310139","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310139?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:06","pubTimestamp":1789956409,"startTime":"0","endTime":"0","summary":"Orthocell  achieved the first commercial sales of its nerve repair product, Remplir, in Thailand, according to a Monday Australian bourse filing.This follows the appointment of MediTime as the company's exclusive in-country distributor for Remplir in the country. Orthocel is supporting the launch and is working with MediTime to train representatives and build engagement.Its shares rose 2% in recent trading on Monday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","OCC.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669364136","title":"Australia's Orthocell Rises as Flagship Product Records First Thailand Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2669364136","media":"Reuters","labels":["productRelease","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669364136?lang=en_us&edition=fundamental","pubTime":"2026-09-21 09:22","pubTimestamp":1789953724,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Orthocell rises as flagship product records first Thailand sales** Shares of OrthocellOCC.AXrise as much as nearly 8% to A$0.745, marking their highest level since September 1** Share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D021:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCC.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":10,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OCC.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.000924}]}}